Persistent Macular Thickening Following Intravitreous Aflibercept, Bevacizumab, or Ranibizumab for Central-Involved Diabetic Macular Edema With Vision Impairment: A Secondary Analysis of a Randomized Clinical Trial.
about
Persistent Macular Thickening Following Intravitreous Aflibercept, Bevacizumab, or Ranibizumab for Central-Involved Diabetic Macular Edema With Vision Impairment: A Secondary Analysis of a Randomized Clinical Trial.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Persistent Macular Thickening ...... f a Randomized Clinical Trial.
@en
Persistent Macular Thickening ...... f a Randomized Clinical Trial.
@nl
type
label
Persistent Macular Thickening ...... f a Randomized Clinical Trial.
@en
Persistent Macular Thickening ...... f a Randomized Clinical Trial.
@nl
prefLabel
Persistent Macular Thickening ...... f a Randomized Clinical Trial.
@en
Persistent Macular Thickening ...... f a Randomized Clinical Trial.
@nl
P2093
P2860
P1433
P1476
Persistent Macular Thickening ...... f a Randomized Clinical Trial.
@en
P2093
Adam R Glassman
Diabetic Retinopathy Clinical Research Network
John A Wells
Kevin J Blinder
Lee M Jampol
Michele Melia
Neil M Bressler
Susan B Bressler
P2860
P304
P356
10.1001/JAMAOPHTHALMOL.2017.6565
P407
P577
2018-02-01T00:00:00Z